These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27347165)
1. Effects of HCG on human epithelial ovarian cancer vasculogenic mimicry formation Gao S; Fan C; Huang H; Zhu C; Su M; Zhang Y Oncol Lett; 2016 Jul; 12(1):459-466. PubMed ID: 27347165 [TBL] [Abstract][Full Text] [Related]
2. Role of hCG in vasculogenic mimicry in OVCAR-3 ovarian cancer cell line. Su M; Wei W; Xu X; Wang X; Chen C; Su L; Zhang Y Int J Gynecol Cancer; 2011 Nov; 21(8):1366-74. PubMed ID: 22027746 [TBL] [Abstract][Full Text] [Related]
3. Involvement of human chorionic gonadotropin in regulating vasculogenic mimicry and hypoxia-inducible factor-1α expression in ovarian cancer cells. Su M; Xu X; Wei W; Gao S; Wang X; Chen C; Zhang Y Cancer Cell Int; 2016; 16():50. PubMed ID: 27346985 [TBL] [Abstract][Full Text] [Related]
4. An HCG-rich microenvironment contributes to ovarian cancer cell differentiation into endothelioid cells in a three-dimensional culture system. Su M; Fan C; Gao S; Shen A; Wang X; Zhang Y Oncol Rep; 2015 Nov; 34(5):2395-402. PubMed ID: 26479853 [TBL] [Abstract][Full Text] [Related]
5. Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo. Su M; Feng YJ; Yao LQ; Cheng MJ; Xu CJ; Huang Y; Zhao YQ; Jiang H Int J Gynecol Cancer; 2008; 18(3):476-86. PubMed ID: 17645504 [TBL] [Abstract][Full Text] [Related]
6. cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer. Tang J; Wang J; Fan L; Li X; Liu N; Luo W; Wang J; Wang Y; Wang Y Oncotarget; 2016 Apr; 7(17):24050-62. PubMed ID: 26992227 [TBL] [Abstract][Full Text] [Related]
7. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo. Gawronska B; Leuschner C; Enright FM; Hansel W Gynecol Oncol; 2002 Apr; 85(1):45-52. PubMed ID: 11925119 [TBL] [Abstract][Full Text] [Related]
8. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter. Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281 [TBL] [Abstract][Full Text] [Related]
9. Expression and production of human chorionic gonadotropin (hCG) in the normal secretory endometrium: evidence of CGB7 and/or CGB6 beta hCG subunit gene expression. Zimmermann G; Ackermann W; Alexander H Biol Reprod; 2012 Mar; 86(3):87. PubMed ID: 21832169 [TBL] [Abstract][Full Text] [Related]
10. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer. Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970 [TBL] [Abstract][Full Text] [Related]
11. Relationship between CD177 and the vasculogenic mimicry, clinicopathological parameters, and prognosis of epithelial ovarian cancer. Jiang J; Chen Y; Zhang M; Zhou H; Wu H Ann Palliat Med; 2020 Nov; 9(6):3985-3992. PubMed ID: 33302660 [TBL] [Abstract][Full Text] [Related]
12. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer. Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171 [TBL] [Abstract][Full Text] [Related]
13. Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Parrott JA; Doraiswamy V; Kim G; Mosher R; Skinner MK Mol Cell Endocrinol; 2001 Feb; 172(1-2):213-22. PubMed ID: 11165055 [TBL] [Abstract][Full Text] [Related]
14. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype. Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974 [TBL] [Abstract][Full Text] [Related]
15. An Overview of Vasculogenic Mimicry in Breast Cancer. Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J Front Oncol; 2020; 10():220. PubMed ID: 32175277 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma. Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413 [TBL] [Abstract][Full Text] [Related]
17. Vasculogenic mimicry is a major feature and novel predictor of poor prognosis in patients with orbital rhabdomyosarcoma. Chen L; He Y; Sun S; Sun B; Tang X Oncol Lett; 2015 Sep; 10(3):1635-1641. PubMed ID: 26622724 [TBL] [Abstract][Full Text] [Related]
18. Vasculogenic mimicry in bladder cancer and its association with the aberrant expression of ZEB1. Li B; Mao X; Wang H; Su G; Mo C; Cao K; Qiu S Oncol Lett; 2018 Apr; 15(4):5193-5200. PubMed ID: 29552157 [TBL] [Abstract][Full Text] [Related]
19. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling. Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140 [TBL] [Abstract][Full Text] [Related]
20. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]